Extra-intestinal pathogenic Escherichia coli (ExPEC): Disease, carriage and clones

Journal of Infection

Volumn 71, Issue 6, 2015, Pages 615-626

  Dale, Adam P ^a   Woodford, Neil ^b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clones; Escherichia coli; ExPEC; Virulence factors

Indexed keywords

ANTIBIOTIC AGENT; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CLONAL VARIATION; DISEASE ASSOCIATION; ESCHERICHIA COLI INFECTION; EVIDENCE BASED MEDICINE; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; GENOMICS; HOST PATHOGEN INTERACTION; HUMAN; INFECTION PREVENTION; MICROBIAL ACTIVITY; MOLECULAR CLONING; NEWBORN INFECTION; NONHUMAN; PHYLOGENY; REVIEW; STANDARDIZATION; URINARY TRACT INFECTION; CLASSIFICATION; ESCHERICHIA COLI; GENETICS; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; SEROTYPING; SYMBIOSIS;

BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTESTINES; PHYLOGENY; SEROTYPING; SYMBIOSIS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84947615792     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.09.009     Document Type: Review

References (97)

1. Frank C., Werber D., Cramer J.P., Askar M., Faber M., an der Heiden M., et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011, 365:1771-1780.
2. WHO Antimicrobial resistance: global report on surveillance 2014, [Internet], WHO, [accessed 11.02.15]. Available from:. http://www.who.int/drugresistance/documents/surveillancereport/en/.
3. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect Inst Pasteur 2003, 5:449-456.
4. Russo T.A., Johnson J.R. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 2000, 181:1753-1754.
5. Peirano G., Mulvey G.L., Armstrong G.D., Pitout J.D.D. Virulence potential and adherence properties of Escherichia coli that produce CTX-M and NDM β-lactamases. J Med Microbiol 2013, 62:525-530.
6. Talan D.A., Stamm W.E., Hooton T.M., Moran G.J., Burke T., Iravani A., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000, 283:1583-1590.
7. Foxman B., Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003, 17:227-241.
8. Brede C.M., Shoskes D.A. The etiology and management of acute prostatitis. Nat Rev Urol 2011, 8:207-212.
9. Chen Y.-H., Hsueh P.-R. Changing bacteriology of abdominal and surgical sepsis. Curr Opin Infect Dis 2012, 25:590-595.
10. Sharma H., Tal R., Clark N.A., Segars J.H. Microbiota and pelvic inflammatory disease. Semin Reprod Med 2014, 32:43-49.
11. Enne V.I., Personne Y., Grgic L., Gant V., Zumla A. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance. Curr Opin Pulm Med 2014, 20:252-258.
12. Kim K.S. Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention. Curr Opin Infect Dis 2012, 25:273-278.
13. Chaudhuri R.R., Henderson I.R. The evolution of the Escherichia coli phylogeny. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis 2012, 12:214-226.
14. Clermont O., Gordon D., Denamur E. A guide to the various phylogenetic classification schemes for Escherichia coli and the correspondence among schemes. Microbiol Read Engl 2015, 161:980-988.
15. Bettelheim K.A., Ismail N., Shinebaum R., Shooter R.A., Moorhouse E., Farrell W. The distribution of serotypes of Escherichia coli in cow-pats and other animal material compared with serotypes of E. coli isolated from human sources. J Hyg (Lond) 1976, 76:403-406.
16. Manges A.R., Johnson J.R. Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis Off Publ Infect Dis Soc Am 2012, 55:712-719.
17. Ochman H., Selander R.K. Standard reference strains of Escherichia coli from natural populations. J Bacteriol 1984, 157:690-693.
18. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
19. Doumith M., Day M.J., Hope R., Wain J., Woodford N. Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol 2012, 50:3108-3110.
20. Turrientes M.-C., González-Alba J.-M., del Campo R., Baquero M.-R., Cantón R., Baquero F., et al. Recombination blurs phylogenetic groups routine assignment in Escherichia coli: setting the record straight. PLoS One 2014, 9:e105395.
21. Clermont O., Christenson J.K., Denamur E., Gordon D.M. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 2013, 5:58-65.
22. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998, 95:3140-3145.
23. Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L.H., et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.
24. Salvador E., Wagenlehner F., Köhler C.-D., Mellmann A., Hacker J., Svanborg C., et al. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012, 80:668-678.
25. Weissman S.J., Johnson J.R., Tchesnokova V., Billig M., Dykhuizen D., Riddell K., et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012, 78:1353-1360.
26. Banerjee R., Johnston B., Lohse C., Chattopadhyay S., Tchesnokova V., Sokurenko E.V., et al. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob Agents Chemother 2013, 57:5912-5917.
27. Salipante S.J., Roach D.J., Kitzman J.O., Snyder M.W., Stackhouse B., Butler-Wu S.M., et al. Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains. Genome Res 2015, 25:119-128.
28. Moreno E., Andreu A., Pérez T., Sabaté M., Johnson J.R., Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006, 134:1015-1023.
29. Moreno E., Andreu A., Pigrau C., Kuskowski M.A., Johnson J.R., Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 2008, 46:2529-2534.
30. Korea C.-G., Ghigo J.-M., Beloin C. The sweet connection: solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: multiple E. coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonisation and tissue tropism. Bioessays News Rev Mol Cell Dev Biol 2011, 33:300-311.
31. Yakovenko O., Sharma S., Forero M., Tchesnokova V., Aprikian P., Kidd B., et al. FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation. J Biol Chem 2008, 283:11596-11605.
32. Thomas W.E., Nilsson L.M., Forero M., Sokurenko E.V., Vogel V. Shear-dependent "stick-and-roll" adhesion of type 1 fimbriated Escherichia coli. Mol Microbiol 2004, 53:1545-1557.
33. Mulvey M.A. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002, 4:257-271.
34. Lane M.C., Mobley H.L.T. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 2007, 72:19-25.
35. Henderson J.P., Crowley J.R., Pinkner J.S., Walker J.N., Tsukayama P., Stamm W.E., et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 2009, 5:e1000305.
36. Wiles T.J., Mulvey M.A. The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives. Future Microbiol 2013, 8:73-84.
37. Barbieri N.L., Nicholson B., Hussein A., Cai W., Wannemuehler Y.M., Dell'Anna G., et al. FNR regulates expression of important virulence factors contributing to pathogenicity of uropathogenic Escherichia coli. Infect Immun 2014, 82:5086-5098.
38. Smith Y.C., Rasmussen S.B., Grande K.K., Conran R.M., O'Brien A.D. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 2008, 76:2978-2990.
39. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000, 181:261-272.
40. Ulett G.C., Totsika M., Schaale K., Carey A.J., Sweet M.J., Schembri M.A. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 2013, 16:100-107.
41. Hannan T.J., Totsika M., Mansfield K.J., Moore K.H., Schembri M.A., Hultgren S.J. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012, 36:616-648.
42. Mabbett A.N., Ulett G.C., Watts R.E., Tree J.J., Totsika M., Ong C.Y., et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol IJMM 2009, 299:53-63.
43. Firoozeh F., Saffari M., Neamati F., Zibaei M. Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2014, 29:219-222.
44. Klinger G., Chin C.N., Beyene J., Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 2000, 106:477-482.
45. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2:123-140.
46. Chu S.-M., Hsu J.-F., Lee C.-W., Lien R., Huang H.-R., Chiang M.-C., et al. Neurological complications after neonatal bacteremia: the clinical characteristics, risk factors, and outcomes. PLoS One 2014, 9:e105294.
47. Dietzman D.E., Fischer G.W., Schoenknecht F.D. Neonatal Escherichia coli septicemia-bacterial counts in blood. J Pediatr 1974, 85:128-130.
48. Wang M.-H., Kim K.S. Cytotoxic necrotizing factor 1 contributes to Escherichia coli meningitis. Toxins 2013, 5:2270-2280.
49. Wooster D.G., Maruvada R., Blom A.M., Prasadarao N.V. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 2006, 117:482-493.
50. Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 2010, 8:26-38.
51. Kim K.S. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008, 6:625-634.
52. Ron E.Z. Distribution and evolution of virulence factors in septicemic Escherichia coli. Int J Med Microbiol IJMM 2010, 300:367-370.
53. Johnson T.J., Wannemuehler Y.M., Nolan L.K. Evolution of the iss gene in Escherichia coli. Appl Environ Microbiol 2008, 74:2360-2369.
54. Macutkiewicz C., Carlson G., Clark E., Dobrindt U., Roberts I., Warhurst G. Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress. Microbes Infect Inst Pasteur 2008, 10:424-431.
55. Bert F., Johnson J.R., Ouattara B., Leflon-Guibout V., Johnston B., Marcon E., et al. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 2010, 48:2709-2714.
56. Mahjoub-Messai F., Bidet P., Caro V., Diancourt L., Biran V., Aujard Y., et al. Escherichia coli isolates causing bacteremia via gut translocation and urinary tract infection in young infants exhibit different virulence genotypes. J Infect Dis 2011, 203:1844-1849.
57. Krawczyk B., Śledzińska A., Szemiako K., Samet A., Nowicki B., Kur J. Characterisation of Escherichia coli isolates from the blood of haematological adult patients with bacteraemia: translocation from gut to blood requires the cooperation of multiple virulence factors. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2015, 34:1135-1143.
58. Duriez P., Clermont O., Bonacorsi S., Bingen E., Chaventré A., Elion J., et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiol Read Engl 2001, 147:1671-1676.
59. Nowrouzian F.L., Wold A.E., Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005, 191:1078-1083.
60. Nielsen K.L., Dynesen P., Larsen P., Frimodt-Møller N. Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol 2014, 63:582-589.
61. Leimbach A., Hacker J., Dobrindt U. E. coli as an all-rounder: the thin line between commensalism and pathogenicity. Curr Top Microbiol Immunol 2013, 358:3-32.
62. Tenaillon O., Skurnik D., Picard B., Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol 2010, 8:207-217.
63. Li B., Sun J., Han L., Huang X., Fu Q., Ni Y. Phylogenetic groups and pathogenicity island markers in fecal Escherichia coli isolates from asymptomatic humans in China. Appl Environ Microbiol 2010, 76:6698-6700.
64. Starčič Erjavec M., Žgur-Bertok D. Virulence potential for extraintestinal infections among commensal Escherichia coli isolated from healthy humans-the Trojan horse within our gut. FEMS Microbiol Lett 2015, 362(5).
65. Nowrouzian F., Wold A.E., Adlerberth I. P fimbriae and aerobactin as intestinal colonization factors for Escherichia coli in Pakistani infants. Epidemiol Infect 2001, 126:19-23.
66. Nowrouzian F., Adlerberth I., Wold A.E. P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol Infect 2001, 126:11-18.
67. Nowrouzian F., Hesselmar B., Saalman R., Strannegard I.-L., Aberg N., Wold A.E., et al. Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 2003, 54:8-14.
68. Vollmerhausen T.L., Ramos N.L., Gündogdu A., Robinson W., Brauner A., Katouli M. Population structure and uropathogenic virulence-associated genes of faecal Escherichia coli from healthy young and elderly adults. J Med Microbiol 2011, 60:574-581.
69. Opal S.M., Girard T.D., Ely E.W. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis Off Publ Infect Dis Soc Am 2005, 41:S504-S512.
70. Wester A.L., Melby K.K., Wyller T.B., Dahle U.R. E. coli bacteremia strains - high diversity and associations with Agerelated clinical Phenomena. Clin Microbiol Open Access 2014, 03(140).
71. Johnson J.R., Clabots C., Kuskowski M.A. Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol 2008, 46:4078-4082.
72. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: "the other bad E coli.". J Lab Clin Med 2002, 139:155-162.
73. Jaureguy F., Landraud L., Passet V., Diancourt L., Frapy E., Guigon G., et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008, 9:560.
74. Adams-Sapper S., Diep B.A., Perdreau-Remington F., Riley L.W. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother 2013, 57:490-497.
75. Horner C., Fawley W., Morris K., Parnell P., Denton M., Wilcox M. Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12). J Antimicrob Chemother 2014, 69:91-100.
76. Gibreel T.M., Dodgson A.R., Cheesbrough J., Fox A.J., Bolton F.J., Upton M. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012, 67:346-356.
77. Kudinha T., Johnson J.R., Andrew S.D., Kong F., Anderson P., Gilbert G.L. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2013, 19:E173-E180.
78. Tchesnokova V., Billig M., Chattopadhyay S., Linardopoulou E., Aprikian P., Roberts P.L., et al. Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J Clin Microbiol 2013, 51:2991-2999.
79. Chung H.-C., Lai C.-H., Lin J.-N., Huang C.-K., Liang S.-H., Chen W.-F., et al. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012, 56:618-622.
80. Petersen A.M., Halkjær S.I., Gluud L.L. Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol 2015, 50:1199-1207.
81. Jauréguy F., Carbonnelle E., Bonacorsi S., Clec'h C., Casassus P., Bingen E., et al. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2007, 13:854-862.
82. Vejborg R.M., Friis C., Hancock V., Schembri M.A., Klemm P. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics MGG 2010, 283:469-484.
83. Achtman M., Mercer A., Kusecek B., Pohl A., Heuzenroeder M., Aaronson W., et al. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 1983, 39:315-335.
84. Doumith M., Day M., Ciesielczuk H., Hope R., Underwood A., Reynolds R., et al. Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 2015, 53:160-166.
85. Mathers A.J., Peirano G., Pitout J.D.D. Escherichia coli ST131: the quintessential example of an international multiresistant high-risk clone. Adv Appl Microbiol 2015, 90:109-154.
86. Colpan A., Johnston B., Porter S., Clabots C., Anway R., Thao L., et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis Off Publ Infect Dis Soc Am 2013, 57:1256-1265.
87. Rogers B.A., Ingram P.R., Runnegar N., Pitman M.C., Freeman J.T., Athan E., et al. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand. Int J Antimicrob Agents 2015, 45:351-358.
88. Price L.B., Johnson J.R., Aziz M., Clabots C., Johnston B., Tchesnokova V., et al. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 2013, 17. e00377-13.
89. Petty N.K., Ben Zakour N.L., Stanton-Cook M., Skippington E., Totsika M., Forde B.M., et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 2014, 111:5694-5699.
90. Banerjee R., Johnson J.R. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2014, 58:4997-5004.
91. Pitout J.D.D. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012, 3:9.
92. Saldaña Z., De la Cruz M.A., Carrillo-Casas E.M., Durán L., Zhang Y., Hernández-Castro R., et al. Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium. PLoS One 2014, 9:e101200.
93. Riegman N., Kusters R., Van Veggel H., Bergmans H., Van Bergen en Henegouwen P., Hacker J., et al. F1C fimbriae of a uropathogenic Escherichia coli strain: genetic and functional organization of the foc gene cluster and identification of minor subunits. J Bacteriol 1990, 172:1114-1120.
94. Kudinha T., Kong F., Johnson J.R., Andrew S.D., Anderson P., Gilbert G.L. Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli. Appl Environ Microbiol 2012, 78:1198-1202.
95. Köhler C.-D., Dobrindt U. What defines extraintestinal pathogenic Escherichia coli?. Int J Med Microbiol IJMM 2011, 301:642-647.
96. Koga V.L., Tomazetto G., Cyoia P.S., Neves M.S., Vidotto M.C., Nakazato G., et al. Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. BioMed Res Int 2014, 2014.
97. Williamson D.A., Mills G., Johnson J.R., Porter S., Wiles S. In vivo correlates of molecularly inferred virulence among extraintestinal pathogenic Escherichia coli (ExPEC) in the wax moth Galleria mellonella model system. Virulence 2014, 5:388-393.